Vanina de Verneuil - Dec 2, 2024 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role
EVP and General Counsel
Signature
/s/ Vanina de Verneuil
Stock symbol
VIR
Transactions as of
Dec 2, 2024
Transactions value $
-$625
Form type
4
Date filed
12/4/2024, 03:35 PM
Previous filing
Nov 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIR Common Stock Sale -$625 -76 -0.13% $8.22 57K Dec 2, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold pursuant to a sale instruction entered into on May 28, 2024, whereby shares purchased on November 29, 2024 pursuant to the Issuer's employee stock purchase program were automatically sold six months after the instruction date.
F2 Reflects ownership after acquisition by the reporting person on November 29, 2024 of 76 shares of common stock pursuant to the Issuer's employee stock purchase program, and sale of such shares on December 2, 2024.